The Lice Treatment Global Market Report 2024 from ResearchAndMarkets.com reveals that there has been a 'global rise in the ...

The Lice Treatment Global Market Report 2024 from ResearchAndMarkets.com reveals that there has been a 'global rise in the ...

Permethrin (1% formulation ... infestation were switched to the alternative treatment. The primary endpoint was absence of live head lice on day 15; secondary outcomes were absence of live ...

However, it is abundantly clear more head-to-head battles like this are needed in the pharmaceutical marketplace. When multiple treatment options are available to patients, a head-to-head clinical ...

With the best flea and tick treatments for cats, you can safely and effectively prevent and eliminate not only fleas and ticks but also parasites like worms and lice. To choose the top cat flea ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

The first-line treatment in many countries is now 5% permethrin, with ivermectin, a promising oral therapy for ordinary scabies. Benzyl benzoate continues to be highly efficacious, although there ...

As important as it is to know the signs and symptoms of sexually transmitted infections (STIs), it sometimes helps to have an actual picture of what different STIs look like. This includes common ...

We worked with dermatologists to find the best acne treatments. Our top picks include prescription tretinoin cream and oral antibiotics as well as OTC salicylic acid toners and niacinamide serums.

Ever heard a voice inside your head that wasn’t your own ... you can talk with a healthcare professional to discuss diagnosis and treatment options. If you hear voices that encourage you ...

“Introducing BrainBridge, the world’s first revolutionary concept for a head transplant machine ... There are a few experimental treatments, but with very, very low numbers of success.” ...

which also points to an increase in voluntary licensing deals – including the first for a cancer treatment (Novartis' nilotinib). "Six companies – Astellas, Boehringer Ingelheim, J&J ...